TG Therapeutics Inc Cash Flow-to-Debt Ratio
TG Therapeutics Inc cash flow-to-debt ratio. TG Therapeutics Inc (TGTX) has a Cash Flow-to-Debt Ratio of 0.02x as of June 2026, meaning its operating cash flow of $21.37 Million could theoretically repay 0% of its total liabilities ($1.04 Billion) in one year. Check cash flow quality index of TG Therapeutics Inc to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of TG Therapeutics Inc (1996–2025)
Cash flow-to-debt ratio of TG Therapeutics Inc from 1996 to 2025. Historical debt coverage capacity for TG Therapeutics Inc across 30 annual periods. Check TGTX cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
TG Therapeutics Inc Cash Flow-to-Debt Ratio by Year (1996–2025)
TG Therapeutics Inc cash flow-to-debt ratio by year from 1996 to 2025. Year-by-year debt coverage analysis for TG Therapeutics Inc. For the full cash flow conversion analysis, see TGTX cash flow metrics.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.06x | $-24.77 Million | $415.23 Million | ▲ +47.7% |
| 2024 | -0.11x | $-40.52 Million | $355.33 Million | ▲ +38.6% |
| 2023 | -0.19x | $-31.41 Million | $169.09 Million | ▲ +85.8% |
| 2022 | -1.31x | $-176.17 Million | $134.99 Million | ▲ +37.1% |
| 2021 | -2.07x | $-295.63 Million | $142.48 Million | ▼ -2.8% |
| 2020 | -2.02x | $-214.51 Million | $106.29 Million | ▼ -89.0% |
| 2019 | -1.07x | $-132.81 Million | $124.40 Million | ▲ +50.7% |
| 2018 | -2.16x | $-128.93 Million | $59.58 Million | ▼ -124.7% |
| 2017 | -0.96x | $-93.76 Million | $97.38 Million | ▲ +14.4% |
| 2016 | -1.12x | $-61.59 Million | $54.78 Million | ▼ -185.5% |
| 2015 | -0.39x | $-44.69 Million | $113.47 Million | ▲ +2.6% |
| 2014 | -0.40x | $-35.06 Million | $86.75 Million | ▼ -79.6% |
| 2013 | -0.22x | $-10.82 Million | $48.11 Million | ▲ +71.7% |
| 2012 | -0.80x | $-5.19 Million | $6.52 Million | ▼ -5660.2% |
| 2011 | -0.01x | $-86.58K | $6.27 Million | ▲ +83.2% |
| 2010 | -0.08x | $-1.97 Million | $24.00 Million | ▲ +44.1% |
| 2009 | -0.15x | $-1.05 Million | $7.15 Million | ▲ +81.4% |
| 2008 | -0.79x | $-4.44 Million | $5.62 Million | ▲ +85.5% |
| 2007 | -5.47x | $-10.23 Million | $1.87 Million | ▼ -37.0% |
| 2006 | -3.99x | $-7.75 Million | $1.94 Million | ▼ -6.4% |
| 2005 | -3.75x | $-6.24 Million | $1.67 Million | ▲ +21.2% |
| 2004 | -4.76x | $-5.69 Million | $1.20 Million | ▼ -33.2% |
| 2003 | -3.57x | $-3.45 Million | $966.02K | ▼ -44.1% |
| 2002 | -2.48x | $-1.43 Million | $577.73K | ▲ +71.8% |
| 2001 | -8.80x | $-4.47 Million | $508.61K | ▼ -1487.3% |
| 2000 | -0.55x | $-1.15 Million | $2.08 Million | ▲ +85.5% |
| 1999 | -3.83x | $-2.30 Million | $600.00K | ▲ +11.5% |
| 1998 | -4.33x | $-2.60 Million | $600.00K | ▲ +57.7% |
| 1997 | -10.25x | $-4.10 Million | $400.00K | ▲ +23.1% |
| 1996 | -13.33x | $-4.00 Million | $300.00K | — |